Brokerages Expect Xylem Inc (XYL) to Post $0.88 EPS

Wall Street brokerages expect Xylem Inc (NYSE:XYL) to report earnings per share (EPS) of $0.88 for the current quarter, according to Zacks. Eight analysts have made estimates for Xylem’s earnings, with estimates ranging from $0.86 to $0.89. Xylem reported earnings of $0.76 per share during the same quarter last year, which would suggest a positive year over year growth rate of 15.8%. The firm is scheduled to announce its next earnings results on Thursday, February 7th.

On average, analysts expect that Xylem will report full year earnings of $2.89 per share for the current fiscal year, with EPS estimates ranging from $2.87 to $2.90. For the next financial year, analysts expect that the firm will report earnings of $3.40 per share, with EPS estimates ranging from $3.30 to $3.56. Zacks Investment Research’s earnings per share averages are a mean average based on a survey of sell-side analysts that follow Xylem.

Xylem (NYSE:XYL) last posted its quarterly earnings results on Tuesday, October 30th. The industrial products company reported $0.77 EPS for the quarter, meeting the consensus estimate of $0.77. Xylem had a net margin of 7.75% and a return on equity of 19.54%. The company had revenue of $1.29 billion for the quarter, compared to analyst estimates of $1.30 billion. During the same period in the prior year, the company earned $0.65 earnings per share. The firm’s revenue was up 7.7% on a year-over-year basis.

Several equities research analysts have commented on the stock. BMO Capital Markets lowered their price target on shares of Xylem from $84.00 to $82.00 and set an “outperform” rating on the stock in a report on Wednesday, October 31st. Credit Suisse Group lowered their price target on shares of Xylem from $86.00 to $81.00 and set an “outperform” rating on the stock in a report on Wednesday, October 31st. Seaport Global Securities set a $80.00 price target on shares of Xylem and gave the company a “buy” rating in a report on Wednesday, October 31st. Royal Bank of Canada reaffirmed a “buy” rating and issued a $77.00 price target on shares of Xylem in a report on Wednesday, October 31st. Finally, ValuEngine lowered shares of Xylem from a “buy” rating to a “hold” rating in a report on Wednesday, October 31st. One research analyst has rated the stock with a sell rating, six have given a hold rating and eight have issued a buy rating to the company. The stock presently has a consensus rating of “Hold” and a consensus target price of $79.57.

In other Xylem news, Director Curtis J. Crawford sold 7,500 shares of the company’s stock in a transaction dated Tuesday, August 7th. The shares were sold at an average price of $76.26, for a total value of $571,950.00. Following the completion of the transaction, the director now owns 40,421 shares in the company, valued at $3,082,505.46. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, insider Colin R. Sabol sold 17,161 shares of the company’s stock in a transaction dated Monday, September 17th. The stock was sold at an average price of $81.37, for a total transaction of $1,396,390.57. Following the completion of the transaction, the insider now owns 41,988 shares of the company’s stock, valued at approximately $3,416,563.56. The disclosure for this sale can be found here. In the last quarter, insiders sold 29,161 shares of company stock valued at $2,327,231. Insiders own 0.81% of the company’s stock.

Several institutional investors have recently modified their holdings of XYL. Flagship Harbor Advisors LLC acquired a new position in shares of Xylem during the 2nd quarter worth about $106,000. Smithfield Trust Co. raised its position in shares of Xylem by 1,690.0% during the 2nd quarter. Smithfield Trust Co. now owns 1,611 shares of the industrial products company’s stock worth $108,000 after purchasing an additional 1,521 shares during the last quarter. Fort L.P. acquired a new position in shares of Xylem during the 2nd quarter worth about $118,000. Stelac Advisory Services LLC acquired a new position in shares of Xylem during the 2nd quarter worth about $125,000. Finally, Pendal Group Ltd acquired a new position in shares of Xylem during the 3rd quarter worth about $126,000. Institutional investors and hedge funds own 84.40% of the company’s stock.

NYSE:XYL traded down $0.14 during mid-day trading on Wednesday, hitting $67.88. The company’s stock had a trading volume of 19,168 shares, compared to its average volume of 1,381,450. Xylem has a 1 year low of $63.71 and a 1 year high of $82.44. The company has a debt-to-equity ratio of 0.83, a quick ratio of 1.07 and a current ratio of 1.49. The firm has a market cap of $12.22 billion, a price-to-earnings ratio of 28.42, a PEG ratio of 1.31 and a beta of 1.24.

The company also recently disclosed a quarterly dividend, which will be paid on Friday, December 7th. Shareholders of record on Thursday, November 1st will be given a $0.21 dividend. The ex-dividend date is Wednesday, October 31st. This represents a $0.84 dividend on an annualized basis and a dividend yield of 1.24%. Xylem’s dividend payout ratio (DPR) is currently 35.00%.

About Xylem

Xylem Inc engages in the design, manufacture, and service of engineered solutions for the water and wastewater applications. It operates through three segments: Water Infrastructure, Applied Water, and Measurement and Control Solutions. The Water Infrastructure segment offers various products, including water and wastewater pumps, and controls and systems, as well as filtration, disinfection, and biological treatment equipment under the Flygt, Godwin, Wedeco, Sanitaire, and Leopold names for the transportation, treatment, and testing of water and wastewater applications.

Featured Story: Marijuana Stocks Future Looks Bright

Get a free copy of the Zacks research report on Xylem (XYL)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Xylem (NYSE:XYL)

Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.


Leave a Reply